FBXW7 and pancreatic neoplasm: In pancreatic cancer, deletion of SETD2 leads to decreased expression of FBXW7, increasing the accumulation of MYC, an FBXW7 substrate, without significantly altering other FBXW7 substrates, such as mTOR and Cyclin E (65).